These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 15689715

  • 1. Cortical hyperexcitability in migraine patients before and after sodium valproate treatment.
    Bowyer SM, Mason KM, Moran JE, Tepley N, Mitsias PD.
    J Clin Neurophysiol; 2005; 22(1):65-7. PubMed ID: 15689715
    [Abstract] [Full Text] [Related]

  • 2. Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS.
    Mulleners WM, Chronicle EP, Vredeveld JW, Koehler PJ.
    Eur J Neurol; 2002 Jan; 9(1):35-40. PubMed ID: 11784374
    [Abstract] [Full Text] [Related]

  • 3. Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients.
    Palmer JE, Chronicle EP, Rolan P, Mulleners WM.
    Cephalalgia; 2000 Jul; 20(6):525-32. PubMed ID: 11075834
    [Abstract] [Full Text] [Related]

  • 4. Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention.
    Welch KM.
    Headache; 2005 Apr; 45 Suppl 1():S25-32. PubMed ID: 15833087
    [Abstract] [Full Text] [Related]

  • 5. Abnormality of visual neuromagnetic activation in female migraineurs without aura between attacks.
    Zhou ZY, Yu YW, Wu D, Liu HX, Xiang J, Wu T, Chen QQ, Wang XS.
    J Headache Pain; 2019 Jan 16; 20(1):7. PubMed ID: 30651072
    [Abstract] [Full Text] [Related]

  • 6. Magnetoencephalographic fields from patients with spontaneous and induced migraine aura.
    Bowyer SM, Aurora KS, Moran JE, Tepley N, Welch KM.
    Ann Neurol; 2001 Nov 16; 50(5):582-7. PubMed ID: 11706963
    [Abstract] [Full Text] [Related]

  • 7. Sustained visual cortex hyperexcitability in migraine with persistent visual aura.
    Chen WT, Lin YY, Fuh JL, Hämäläinen MS, Ko YC, Wang SJ.
    Brain; 2011 Aug 16; 134(Pt 8):2387-95. PubMed ID: 21729907
    [Abstract] [Full Text] [Related]

  • 8. Modulation of visual cortex excitability in migraine with aura: effects of valproate therapy.
    Palermo A, Fierro B, Giglia G, Cosentino G, Puma AR, Brighina F.
    Neurosci Lett; 2009 Dec 18; 467(1):26-9. PubMed ID: 19800389
    [Abstract] [Full Text] [Related]

  • 9. Abnormal cortical activation in females with acute migraine: a magnetoencephalography study.
    Ge HT, Liu HX, Xiang J, Miao AL, Tang L, Guan QS, Wu T, Chen QQ, Yang L, Wang XS.
    Clin Neurophysiol; 2015 Jan 18; 126(1):170-9. PubMed ID: 24854723
    [Abstract] [Full Text] [Related]

  • 10. Migraine with visual aura and photosensitive epileptic seizures.
    Donnet A, Bartolomei F.
    Epilepsia; 1997 Sep 18; 38(9):1032-4. PubMed ID: 9579943
    [Abstract] [Full Text] [Related]

  • 11. [Sodium valproate versus propranolol in the prophylactic treatment of migraine].
    Kozubski W, Prusiński A.
    Neurol Neurochir Pol; 1995 Sep 18; 29(6):937-47. PubMed ID: 8714731
    [Abstract] [Full Text] [Related]

  • 12. Peri-ictal normalization of visual cortex excitability in migraine: an MEG study.
    Chen WT, Wang SJ, Fuh JL, Lin CP, Ko YC, Lin YY.
    Cephalalgia; 2009 Nov 18; 29(11):1202-11. PubMed ID: 19558536
    [Abstract] [Full Text] [Related]

  • 13. Functional MRI as a biomarker for evaluation and prediction of effectiveness of migraine prophylaxis.
    Huang J, Cao Y.
    Biomark Med; 2012 Aug 18; 6(4):517-27. PubMed ID: 22917153
    [Abstract] [Full Text] [Related]

  • 14. Transcranial direct current stimulation in the prophylactic treatment of migraine based on interictal visual cortex excitability abnormalities: A pilot randomized controlled trial.
    Rocha S, Melo L, Boudoux C, Foerster Á, Araújo D, Monte-Silva K.
    J Neurol Sci; 2015 Feb 15; 349(1-2):33-9. PubMed ID: 25579414
    [Abstract] [Full Text] [Related]

  • 15. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial.
    Mitsikostas DD, Polychronidis I.
    Funct Neurol; 1997 Feb 15; 12(5):267-76. PubMed ID: 9439944
    [Abstract] [Full Text] [Related]

  • 16. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study.
    Jensen R, Brinck T, Olesen J.
    Neurology; 1994 Apr 15; 44(4):647-51. PubMed ID: 8164818
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.
    Waberzinek G, Marková J, Mastík J.
    Neuro Endocrinol Lett; 2007 Feb 15; 28(1):59-64. PubMed ID: 17277725
    [Abstract] [Full Text] [Related]

  • 18. Migraine preventive drugs differentially affect cortical spreading depression in rat.
    Bogdanov VB, Multon S, Chauvel V, Bogdanova OV, Prodanov D, Makarchuk MY, Schoenen J.
    Neurobiol Dis; 2011 Feb 15; 41(2):430-5. PubMed ID: 20977938
    [Abstract] [Full Text] [Related]

  • 19. Local and global motion after-effects are both enhanced in migraine, and the underlying mechanisms differ across cortical areas.
    Shepherd AJ.
    Brain; 2006 Jul 15; 129(Pt 7):1833-43. PubMed ID: 16684787
    [Abstract] [Full Text] [Related]

  • 20. Effects of repetitive transcranial magnetic stimulation on visual evoked potentials in migraine.
    Bohotin V, Fumal A, Vandenheede M, Gérard P, Bohotin C, Maertens de Noordhout A, Schoenen J.
    Brain; 2002 Apr 15; 125(Pt 4):912-22. PubMed ID: 11912123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.